[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Facial Injectables Market Report 2018

March 2018 | 110 pages | ID: U5331758778QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Facial Injectables market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Facial Injectables in these regions, from 2013 to 2025 (forecast).
United States Facial Injectables market competition by top manufacturers/players, with Facial Injectables sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Allergan
  • Prollenium Medical Technologies Inc
  • Galderma
  • Merz Aesthetics
  • Ipsen Group
  • Bloomage BioTechnology
  • Hangzhou Techderm Biological Products
  • Laboratory Obvieline
  • Medytox
  • Polymekon
  • Qufu Guanglong Biochem
  • Revitacare
  • Suneva Medical
  • SciVision Biotech
  • Speciality European Pharma
  • Syneron
  • Visionmed
  • AQTIS Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Botulinum Toxin
  • Hyaluronic Acid
  • Collagen
  • Particle & Polymer Fillers (PPF)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Ambulatory Surgical Centers
  • Cosmetic Centers
  • Dermatology Clinics
  • Physician Clinics
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Facial Injectables Market Report 2018

1 FACIAL INJECTABLES OVERVIEW

1.1 Product Overview and Scope of Facial Injectables
1.2 Classification of Facial Injectables by Product Category
  1.2.1 United States Facial Injectables Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Facial Injectables Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Botulinum Toxin
  1.2.4 Hyaluronic Acid
  1.2.5 Collagen
  1.2.6 Particle & Polymer Fillers (PPF)
1.3 United States Facial Injectables Market by Application/End Users
  1.3.1 United States Facial Injectables Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Cosmetic Centers
  1.3.5 Dermatology Clinics
  1.3.6 Physician Clinics
1.4 United States Facial Injectables Market by Region
  1.4.1 United States Facial Injectables Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Facial Injectables Status and Prospect (2013-2025)
  1.4.3 Southwest Facial Injectables Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Facial Injectables Status and Prospect (2013-2025)
  1.4.5 New England Facial Injectables Status and Prospect (2013-2025)
  1.4.6 The South Facial Injectables Status and Prospect (2013-2025)
  1.4.7 The Midwest Facial Injectables Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Facial Injectables (2013-2025)
  1.5.1 United States Facial Injectables Sales and Growth Rate (2013-2025)
  1.5.2 United States Facial Injectables Revenue and Growth Rate (2013-2025)

2 UNITED STATES FACIAL INJECTABLES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Facial Injectables Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Facial Injectables Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Facial Injectables Average Price by Players/Suppliers (2013-2018)
2.4 United States Facial Injectables Market Competitive Situation and Trends
  2.4.1 United States Facial Injectables Market Concentration Rate
  2.4.2 United States Facial Injectables Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FACIAL INJECTABLES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Facial Injectables Sales and Market Share by Region (2013-2018)
3.2 United States Facial Injectables Revenue and Market Share by Region (2013-2018)
3.3 United States Facial Injectables Price by Region (2013-2018)

4 UNITED STATES FACIAL INJECTABLES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Facial Injectables Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Facial Injectables Revenue and Market Share by Type (2013-2018)
4.3 United States Facial Injectables Price by Type (2013-2018)
4.4 United States Facial Injectables Sales Growth Rate by Type (2013-2018)

5 UNITED STATES FACIAL INJECTABLES SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Facial Injectables Sales and Market Share by Application (2013-2018)
5.2 United States Facial Injectables Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES FACIAL INJECTABLES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Facial Injectables Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Prollenium Medical Technologies Inc
  6.2.2 Facial Injectables Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Prollenium Medical Technologies Inc Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Galderma
  6.3.2 Facial Injectables Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Galderma Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Merz Aesthetics
  6.4.2 Facial Injectables Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merz Aesthetics Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ipsen Group
  6.5.2 Facial Injectables Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ipsen Group Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Bloomage BioTechnology
  6.6.2 Facial Injectables Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bloomage BioTechnology Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Hangzhou Techderm Biological Products
  6.7.2 Facial Injectables Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Laboratory Obvieline
  6.8.2 Facial Injectables Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Laboratory Obvieline Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Medytox
  6.9.2 Facial Injectables Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Medytox Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Polymekon
  6.10.2 Facial Injectables Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Polymekon Facial Injectables Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Qufu Guanglong Biochem
6.12 Revitacare
6.13 Suneva Medical
6.14 SciVision Biotech
6.15 Speciality European Pharma
6.16 Syneron
6.17 Visionmed
6.18 AQTIS Medical

7 FACIAL INJECTABLES MANUFACTURING COST ANALYSIS

7.1 Facial Injectables Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Facial Injectables

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Facial Injectables Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Facial Injectables Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FACIAL INJECTABLES MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Facial Injectables Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Facial Injectables Sales Volume Forecast by Type (2018-2025)
11.3 United States Facial Injectables Sales Volume Forecast by Application (2018-2025)
11.4 United States Facial Injectables Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Facial Injectables
Figure United States Facial Injectables Market Size (K Doses) by Type (2013-2025)
Figure United States Facial Injectables Sales Volume Market Share by Type (Product Category) in 2017
Figure Botulinum Toxin Product Picture
Figure Hyaluronic Acid Product Picture
Figure Collagen Product Picture
Figure Particle & Polymer Fillers (PPF) Product Picture
Figure United States Facial Injectables Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Facial Injectables by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Cosmetic Centers Examples
Table Key Downstream Customer in Cosmetic Centers
Figure Dermatology Clinics Examples
Table Key Downstream Customer in Dermatology Clinics
Figure Physician Clinics Examples
Table Key Downstream Customer in Physician Clinics
Figure United States Facial Injectables Market Size (Million USD) by Region (2013-2025)
Figure The West Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Facial Injectables Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Facial Injectables Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Facial Injectables Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Facial Injectables Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Facial Injectables Sales Share by Players/Suppliers
Figure 2017 United States Facial Injectables Sales Share by Players/Suppliers
Figure United States Facial Injectables Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Facial Injectables Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Facial Injectables Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Facial Injectables Revenue Share by Players/Suppliers
Figure 2017 United States Facial Injectables Revenue Share by Players/Suppliers
Table United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Facial Injectables Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Facial Injectables Market Share of Top 3 Players/Suppliers
Figure United States Facial Injectables Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Facial Injectables Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Facial Injectables Product Category
Table United States Facial Injectables Sales (K Doses) by Region (2013-2018)
Table United States Facial Injectables Sales Share by Region (2013-2018)
Figure United States Facial Injectables Sales Share by Region (2013-2018)
Figure United States Facial Injectables Sales Market Share by Region in 2017
Table United States Facial Injectables Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Facial Injectables Revenue Share by Region (2013-2018)
Figure United States Facial Injectables Revenue Market Share by Region (2013-2018)
Figure United States Facial Injectables Revenue Market Share by Region in 2017
Table United States Facial Injectables Price (USD/Dose) by Region (2013-2018)
Table United States Facial Injectables Sales (K Doses) by Type (2013-2018)
Table United States Facial Injectables Sales Share by Type (2013-2018)
Figure United States Facial Injectables Sales Share by Type (2013-2018)
Figure United States Facial Injectables Sales Market Share by Type in 2017
Table United States Facial Injectables Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Facial Injectables Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Facial Injectables by Type (2013-2018)
Figure Revenue Market Share of Facial Injectables by Type in 2017
Table United States Facial Injectables Price (USD/Dose) by Types (2013-2018)
Figure United States Facial Injectables Sales Growth Rate by Type (2013-2018)
Table United States Facial Injectables Sales (K Doses) by Application (2013-2018)
Table United States Facial Injectables Sales Market Share by Application (2013-2018)
Figure United States Facial Injectables Sales Market Share by Application (2013-2018)
Figure United States Facial Injectables Sales Market Share by Application in 2017
Table United States Facial Injectables Sales Growth Rate by Application (2013-2018)
Figure United States Facial Injectables Sales Growth Rate by Application (2013-2018)
Table Allergan Basic Information List
Table Allergan Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Allergan Facial Injectables Sales Growth Rate (2013-2018)
Figure Allergan Facial Injectables Sales Market Share in United States (2013-2018)
Figure Allergan Facial Injectables Revenue Market Share in United States (2013-2018)
Table Prollenium Medical Technologies Inc Basic Information List
Table Prollenium Medical Technologies Inc Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Growth Rate (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Sales Market Share in United States (2013-2018)
Figure Prollenium Medical Technologies Inc Facial Injectables Revenue Market Share in United States (2013-2018)
Table Galderma Basic Information List
Table Galderma Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Galderma Facial Injectables Sales Growth Rate (2013-2018)
Figure Galderma Facial Injectables Sales Market Share in United States (2013-2018)
Figure Galderma Facial Injectables Revenue Market Share in United States (2013-2018)
Table Merz Aesthetics Basic Information List
Table Merz Aesthetics Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merz Aesthetics Facial Injectables Sales Growth Rate (2013-2018)
Figure Merz Aesthetics Facial Injectables Sales Market Share in United States (2013-2018)
Figure Merz Aesthetics Facial Injectables Revenue Market Share in United States (2013-2018)
Table Ipsen Group Basic Information List
Table Ipsen Group Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ipsen Group Facial Injectables Sales Growth Rate (2013-2018)
Figure Ipsen Group Facial Injectables Sales Market Share in United States (2013-2018)
Figure Ipsen Group Facial Injectables Revenue Market Share in United States (2013-2018)
Table Bloomage BioTechnology Basic Information List
Table Bloomage BioTechnology Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Sales Growth Rate (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Sales Market Share in United States (2013-2018)
Figure Bloomage BioTechnology Facial Injectables Revenue Market Share in United States (2013-2018)
Table Hangzhou Techderm Biological Products Basic Information List
Table Hangzhou Techderm Biological Products Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Growth Rate (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Sales Market Share in United States (2013-2018)
Figure Hangzhou Techderm Biological Products Facial Injectables Revenue Market Share in United States (2013-2018)
Table Laboratory Obvieline Basic Information List
Table Laboratory Obvieline Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Laboratory Obvieline Facial Injectables Sales Growth Rate (2013-2018)
Figure Laboratory Obvieline Facial Injectables Sales Market Share in United States (2013-2018)
Figure Laboratory Obvieline Facial Injectables Revenue Market Share in United States (2013-2018)
Table Medytox Basic Information List
Table Medytox Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Medytox Facial Injectables Sales Growth Rate (2013-2018)
Figure Medytox Facial Injectables Sales Market Share in United States (2013-2018)
Figure Medytox Facial Injectables Revenue Market Share in United States (2013-2018)
Table Polymekon Basic Information List
Table Polymekon Facial Injectables Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Polymekon Facial Injectables Sales Growth Rate (2013-2018)
Figure Polymekon Facial Injectables Sales Market Share in United States (2013-2018)
Figure Polymekon Facial Injectables Revenue Market Share in United States (2013-2018)
Table Qufu Guanglong Biochem Basic Information List
Table Revitacare Basic Information List
Table Suneva Medical Basic Information List
Table SciVision Biotech Basic Information List
Table Speciality European Pharma Basic Information List
Table Syneron Basic Information List
Table Visionmed Basic Information List
Table AQTIS Medical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Facial Injectables
Figure Manufacturing Process Analysis of Facial Injectables
Figure Facial Injectables Industrial Chain Analysis
Table Raw Materials Sources of Facial Injectables Major Players/Suppliers in 2017
Table Major Buyers of Facial Injectables
Table Distributors/Traders List
Figure United States Facial Injectables Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Facial Injectables Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Facial Injectables Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Type in 2025
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Facial Injectables Sales Volume (K Doses) Forecast by Application in 2025
Table United States Facial Injectables Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Facial Injectables Sales Volume Share Forecast by Region (2018-2025)
Figure United States Facial Injectables Sales Volume Share Forecast by Region (2018-2025)
Figure United States Facial Injectables Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications